Description1 - Michigan Medicine | University of Michigan
The avibactam component protects ceftazidime from the degradation of some beta-lactamases and extended- spectrum beta-lactamases (ESBLs), and has specifically ... was compared to meropenem for the treatment of cIAI and to imipenem-cilastatin for the treatment of cUTI in two phase II trials. ... given every 8 hours by intravenous infusion over 2 ... ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- university of michigan admissions staff
- university of michigan admission requirement
- university of michigan sat scores
- university of michigan payroll office
- university of michigan application deadline
- university of michigan act requirements
- university of michigan entrance requirements
- university of michigan transfer deadline
- university of michigan philosophy dept
- university of michigan applicant portal
- university of michigan neurology
- university of michigan hospital neurology